TRIB2 and neoplasm: In contrast, 293T-TRIB2 tumours were highly resistant to treatment, correlating with our in vitro studies indicating that TRIB2 over expression significantly reduced the effectiveness of BEZ235 treatment in vivo (Fig. 4a,b).